Table 1.

Prevalence of various liver conditions in the Nottingham study and, based on this, the prevalence expected if those likely to have a scan suggesting fatty liver are excluded

Various liver conditions	Prevalence (%) in Nottingham study	Projected prevalence (%) in those expected to have a negative scan for fat
NAFLD or NASH	66	19
Drug related damage	8	19
Cryptogenic hepatitis	9	21
Alcoholic damage	3	7
AIH	1.9	4.5
Granuloma/sarcoid	1.7	4
PBC	1.4	3.3
PSC	1.1	2.6
Haemochromatosis	0.9	2.1
Secondary biliary cirrhosis	0.6	1.4
Amyloid	0.3	0.7
Glycogen storage disease	0.3	0.7
Normal	6	14

NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; AIH, autoimmune hepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.